Exposed to opioids before birth, some newborns experience a painful withdrawal, a condition known as NOWS. Common symptoms include frantic breathing, racing heartrates, constant crying, even tremors and seizures. We are pursuing FDA clearance to improve the treatment of NOWS to help newborns and their caregivers.
Apnea of Prematurity
Premature infants who stop breathing for 20 seconds or more during sleep are often diagnosed with apnea of prematurity (AOP). When they stop breathing, their heart rate drops below 80 beats per minute, they turn bluish and pale and appear limp. As a pediatric biotechnology startup we are excited to have the opportunity to improve AOP treatment by reducing or eliminating the use of drug therapy, specifically caffeine.